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ABSTRACT 
Charcot-Marie-Tooth disease is a rare peripheral neuropathy for which there is no specific 
treatment. Some forms of Charcot-Marie-Tooth are due to mutations in the GDAP1 gene. A 
striking feature of mutations in GDAP1 is that they have a variable clinical manifestation, 
according to disease onset and progression, histology and mode of inheritance. Studies in 
cellular and animal models have revealed a role of GDAP1 in mitochondrial morphology and 
distribution, calcium homeostasis and oxidative stress. To get a better understanding of the 
disease mechanism we have generated models of over-expression and RNA interference of 
the Drosophila Gdap1 gene. In order to get an overview about the changes that Gdap1 
mutations cause in our disease model, we have combined a comprehensive determination of 
the metabolic profile in the flies by nuclear magnetic resonance spectroscopy with gene 
expression analyses and biophysical tests. Our results revealed that both up- and down-
regulation of Gdap1 results in an early systemic inactivation of the insulin pathway before the 
onset of neuromuscular degeneration, followed by an accumulation of carbohydrates and an 
increase in the β-oxidation of lipids. 
Our findings are in line with emerging reports of energy metabolism impairments linked to 
different types of neural pathologies caused by defective mitochondrial function, which is not 
surprising given the central role of mitochondria in the control of energy metabolism. The 
relationship of mitochondrial dynamics with metabolism during neurodegeneration opens new 
avenues to understand the cause of the disease, and for the discovery of new biomarkers and 
treatments. 
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1. INTRODUCTION 
The Charcot-Marie-Tooth (CMT) disease (ICD-10: G60.0) refers to those forms of inherited 
peripheral neuropathies in which both the motor and sensory functions are affected [1]. 
Despite the fact that there are several types of CMT, collectively they affect one in 2.500 
people, so it is considered a rare disease. In CMT, neuromuscular degeneration is dependent 
on the length of the axon, so it affects primarily the long nerves of the limbs, starting with the 
lower limbs. The loss of muscle mass results in deformities in foot and hand (pes cavus, 
hammertoes, claw hands) and in an “inverted champagne bottle” appearance of the distal leg. 
There are two main clinical forms of CMT that are classified according to motor nerve 
conduction velocity in the upper limb nerves, Demyelinating CMT (CMT1) is characterized 
by a decreased motor nerve conduction velocity (<38 m/s) and dysmyelination traits in sural 
nerve biopsies; while axonal CMT (CMT2) patients present normal or slightly reduced motor 
nerve conduction velocity (>42 m/s) and no dysmyelination phenotypes despite a reduction in 
the number of axons [1, 2]. CMT is also a genetically heterogeneous disease, with over 50 
genes harbouring CMT-causative mutations and all major modes of inheritance: autosomal 
recessive, autosomal dominant and X-linked. 
Two of the most common causative genes for axonal CMT2, MFN2 and GDAP1, are involved 
in mitochondrial dynamics. Many studies have described mitochondrial dynamics as an 
underlying cause for neurodegenerative diseases [3]. The balance of mitochondrial fission and 
fusion contributes primarily to mitochondrial morphology, but it is also crucial for the correct 
localization of these organelles within the cell and for several processes such as oxidative 
phosporylation, autophagy, calcium homeostasis, cell differentiation and cell death [4]. 
Mutations in the GDAP1 gene have been found to be a cause of at least 4 different subtypes of 
Charcot-Marie-Tooth (A, 2K, 4A and autosomal recessive CMT with hoarseness) and is also 
a candidate causative gene for CMT2H [5, 6]; and the GDAP1 protein, located in the 
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mitochondrial outer membrane, has been described as a fission factor regulating the 
mitochondrial network [7, 8], peroxisome morphology [9] and store-operated calcium entry 
dependent on ER-mitochondria contacts [10]. Two murine models of Gdap1 knock-out show 
peripheral neuropathy and alterations in oxidative stress and store-operated calcium entry [11, 
12]. A Drosophila model of GDAP1 reproduces the hallmarks of neuromuscular 
degeneration, and has revealed mitochondrial morphology and distribution alterations as early 
features, and oxidative stress alterations as a late-onset consequence of altered levels of the 
protein [13]. 
Mitochondrial dynamics is intimately associated with neurodegeneration [14], but 
mitochondria are also central organelles in the control of metabolism and mitochondrial 
dynamics has a leading role in metabolic diseases such as diabetes and obesity [15]. 
Therefore, it is not surprising that there is mounting evidence of concomitant metabolic and 
neural dysfunctions. For example, an increase in mitochondrial fission and disturbance in 
tricarboxylic acid (TCA) cycle metabolites associated with Alzheimer disease, or an alteration 
in glucose and coenzyme Q homeostasis triggered by the ablation of CMT-related Mfn2 [16, 
17]. 
We decided to use Drosophila to investigate metabolic changes caused by altered Gdap1 
expression with the aims to have a better understanding of the CMT pathophysiology and to 
reveal metabolic alterations that could lead to the discovery of biomarkers of diagnostic and 
prognostic value, which is a priority in CMT translational research [18]. The global metabolic 
profile analysis of our Drosophila disease model by nuclear magnetic resonance (NMR) 
spectroscopy in combination with the quantification by PCR and Western blotting of related 
pathway genes and proteins reveals extensive alterations in the energy metabolism and a dys-
regulation of the insulin signaling pathway. These results are discussed in the context of what 
is known about the clinical genotype-phenotype correlation. 
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RESULTS 
1.1. Gdap1 levels influence fitness and age-related neuromuscular competence 
To identify systemic alterations associated with the pathophysiology of GDAP1-related CMT, 
Drosophila Gdap1 levels were altered in the whole animal using the UAS/Gal4 technique 
[19]. A ubiquitous driver, Ac5C-Gal4, was used to express a Gdap1 cDNA (kick-up, KU 
flies) and an RNAi directed against the gene (knock-down, KD flies). These constructs have 
been previously validated for up- and down-regulation of  Gdap1 expression [13]. Both KU 
and KD genotypes compromise the viability of the animals (Fig. 1A), since they reduce the 
maximum lifespan, 90 days, by 40 and 20 days, respectively. In addition, both genotypes also 
have a reduced neuromuscular competence measured in a negative geotaxis assay (Fig. 1B 
and Video S1); and they suffer a progressive deterioration in the ability to climb the vial wall, 
although this defect was more pronounced in the KD flies. Therefore, the more reduced 
viability of KU is not due to a lower neuromuscular competence, and other factors must 
contribute to this. Finally, we calculated the average body weight per individual as an 
indication of the overall metabolic alterations, and found a significant reduction in older KU 
flies (Fig. 1C).  
 
Figure 1. Overall fitness of KU and KD genotypes compared to the control. A. Survival 
curves of the three genotypes represented as percentage of surviving flies. B. Negative 
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geotaxis assay at 10, 20 and 30 days of age. C. Average body weight at 1 and 5 weeks. In bar 
diagrams data are represented as mean ±SEM. *P<0.05, ***P<0.001. 
 
1.2. Impact of Gdap1 expression on the general metabolic profile 
As mitochondrial defects can have an impact in several metabolic pathways, we decided to 
analyze the alterations in the metabolome of the KU and KD genotypes by NMR 
spectroscopy. We performed metabolomic analyses at two ages, 1 week and 5 weeks of adult 
life (henceforth, young and old flies), to detect early alterations that may be related to the 
cause of the neuromuscular degeneration, and later ones, that could reflect the progression of 
the phenotype. We characterized the metabolic profile of polar and non-polar fly extracts by 
high resolution NMR, and of intact fly tissue by High Resolution Magic Angle Spinning (HR-
MAS) (Figure 2). 
A detailed analysis of the spectral peaks in all three genotypes is shown in Tables S1 to S5. 
After metabolite assignment, the relative abundance of each metabolite in all three genotypes 
was determined to evalute the differences between each set. This evaluation was followed by 
a multivariate statistical analysis to identify the most significant changes in the metabolic 
profiles. Orthogonal projection on latent structure-discriminant analysis (OPLS-DA) was 
performed to build the models based on the metabolic differences of Gdap1 KU and KD 
genotypes compared to control flies at both time periods. In the case of young flies, it was not 
possible to obtain a reliable model, separating KU or KD flies from the control ones. 
However, good quality models were obtained for old flies, with R2 values close to 1, and Q2 
values>0.5. (Fig. 3A, B). This is in agreement with our previous work [13], where no 
significant physiological differences were detected in young flies. 
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Figure 2. Representative NMR spectra of fly extracts with peak assignation. The spectra 
for the aqueous phase (blue), the organic phase (green) and HR-MAS (red) of a control 
sample are shown. The labels above the peaks correspond to the same identifiers indicated in 
Tables S1 to S5. The highest diversity of metabolites was detected in the aqueous phase, 
which included sugars, amino acids, organic acids, nucleotides and other key metabolites of 
the energetic and phospholipid metabolism. The spectrum of the organic phase presented 
broader signals and contained mainly lipids. NMR spectroscopy only allows the identification 
of the functional groups of different lipid types due to the high degree of overlapping. In 
addition to conventional NMR spectroscopy, we obtained HR-MAS spectra of intact tissue, 
containing both polar and nonpolar metabolites. Although the resolution of these spectra is 
much lower, this technique allows the analysis of the whole living fly without any tissue 
processing and allows a better detection of more mobile molecules, which could provide 
interesting additional information concerning the lipid profile. 
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In these 5-week old flies the S-plots showed the most relevant metabolites involved in the 
discrimination (Fig. 3A, B). The most relevant changes belonged to carbohydrates, some of 
which were elevated in KU (myo-inositol), KD (glucose, glycogen, trehalose) or both 
(fructose); and in amino acids, whose levels were generally reduced in both genotypes, with 
the exception of alanine (elevated in KU) and arginine (elevated in KD). Both models showed 
an increase in glycerophosphocholine (GPC), a metabolite that accumulates in cerebrospinal 
fluid of Alzheimer patients as a result of membrane phospholipid degradation during 
neurodegeneration [20]. 
 
Figure 3. Metabolic profile of KU and KD genotypes compared to the control. A. OPLS-
DA score plot comparing KU flies to control flies at five weeks of age and corresponding S 
plot, color coded circles enclose the metabolites that are most relevant for the separation. B. 
The same analysis was performed to compare KD flies to control flies. 
 
It is worth mentioning that although both genotypes showed the same trends in some types of 
metabolites, a discriminant model for KU compared to KD was also built (see Supplementary 
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Material Fig S1), which means that although similar metabolic routes may be affected in both 
cases (see below), the two genotypes have two distinct metabolic profiles. 
In summary, the most significant metabolic changes in KU and KD genotypes point to 
alterations in the levels of free amino acids and, most remarkably, in the carbohydrate 
metabolism. These metabolites provided a starting point to investigate additional metabolites 
exhibiting statistical significance that could provide clues to the biological function of Gdap1. 
In addition, we have studied the expression levels of enzymes that regulate the pathways 
involved in metabolite abundance. Since young flies do not have many relevant changes, 
these analyses only focused on old flies. 
 
1.3. The amino acid profile is consistent with a protein anabolism/catabolism 
imbalance 
In Fig. 4A, a more detailed overview of the differences in amino acids in old flies is shown. 
There is a consistent reduction in the amounts of β-alanine, aspartate, isoleucine, leucine, 
valine and tyrosine, and an increase of alanine in KU and of arginine in KD. Several lines of 
evidence indicate that these results are associated with a catabolic process. This set includes 
the three branched-chain amino acids, which promote protein synthesis in the muscle [21]. 
Our profile is very similar to the amino acid abundance in plasma of amyotrophic lateral 
sclerosis patients [22]. In this regard,, patients had reduced levels of aspartate, isoleucine, 
leucine, valine and tyrosine compared to healthy controls. In addition, higher levels of alanine 
were linked to a clinical terminal state and higher levels of arginine to faster progression of 
the disease. A reduction in the muscular metabolite β-alanine has been associated with muscle 
degeneration in Drosophila [23]. 
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Figure 4. Alterations in amino acid and carbohydrate homeostasis in 5-week old flies. A. 
Relative NMR signals of amino acids with significant changes. B. Relative NMR signals of 
carbohydrates with significant changes. C. Schematic representation of the metabolic 
pathways of carbohydrates and extra-mitochondrial pyruvate, with indication of the key 
enzymes quantitated in our work. D. Relative mRNA level of carbohydrate metabolism 
enzymes. E. Relative mRNA levels of pyruvate metabolism enzymes. In bar diagrams data 
are represented as mean ±SEM. *P<0.05, **P<0.01. 
 
1.4. Alterations in Gdap1 levels translate into accumulation of carbohydrates 
A general trend in the metabolic profile of old KU and KD flies is an average increase in 
carbohydrates (Fig. 4B). In KD flies we found a significant increase in glucose, fructose, 
trehalose and glycogen, and an increase of fructose levels in KU flies. In agreement with this 
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finding, both genotypes had increased transcript levels of the gluconeogenesis regulator 
phosphoenolpyruvate carboxykinase (PEPCK) and the glycogen synthase (GlyS); and 
reduced levels of the glycolytic enzyme pyruvate kinase (PyrK) and the glycogenolytic 
enzyme glycogen phosphorylase (GlyP) (Fig. 4C, D). In summary, altering Gdap1 levels 
causes an accumulation of different carbohydrates and a transcriptional response in favor of 
anabolism and against catabolism of carbohydrates.  
Despite this accumulation of carbohydrates, pyruvate levels were slightly increased rather 
than reduced (see below), so we tested two other branching pathways for pyruvate 
metabolism towards alanine and lactate (Fig 4C). Although alanine was elevated, more 
significantly in KU, no significant alterations were detected in the expression of alanine 
transaminase (ALT) and lactate dehydrogenase (LDH) (Fig 4E). 
 
1.5. Modified Gdap1 levels trigger a switch-over in the energy use 
Pyruvate is the bridge between glycolysis and the TCA cycle, and its levels are controlled by 
the pyruvate dehydrogenase complex (PDC), which regulates the entry of glycolytic products 
to the TCA cycle, converting pyruvate to acetyl-CoA (Fig. 5A). The activity of PDC is tightly 
controlled by both, the inhibitor pyruvate dehydrogenase kinase (PDK) and the activator 
pyruvate dehydrogenase phosphatase (PDP)[24]. Both enzymes are regulated at the 
transcriptional level, and in our study we found that KD flies had reduced levels of PDP and 
both KU and KD had elevated levels of the inhibitor PDK (Fig. 5B). In addition to its 
transcriptional control, PDK acts as a sensor of physiological information to regulate PDC: a 
high ratio NADH/NAD+ and high levels of mitochondrial ATP activate PDK, which in turn 
inhibits the activity of PDC. Regarding these two parameters, both genotypes showed a high 
ratio NADH/NAD+ and also high levels of mitochondrial ATP (Fig. 5B). These results 
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suggest that PDC must be down-regulated and this would explain that there is no reduction in 
pyruvate levels despite the glycolysis was impaired. However, the abundances of some of the 
most important TCA cycle metabolites were similar to the control (Fig. 5C), suggesting 
compensatory changes in the production of acetyl-CoA to maintain the homeostasis of TCA 
cycle. If glycolisis is impaired, there must be an alternative anaplerotic pathway to feed the 
TCA cycle, such as lipid oxidation. This could also explain the decrease in NADH/NAD+ 
ratio and ATP, since lipolysis is more energetic than oxidative phosphorylation via glycolysis 
and TCA cycle. In fact, PDC is the main regulator of the choice of carbohydrates or lipids as 
metabolic fuel [25]. 
To detect changes in lipid metabolism, we explored HR-MAS spectra, since they provide 
predominantly signals from dynamic lipids, reducing the interference of the more static 
membrane lipids (Fig. 5D). We observed a reduction in the amount of total lipids in KU and 
KD flies. In addition, we carried out a more detailed analysis of specific lipid types; 
unsaturated lipids, esterified lipids, triacylglycerols and phospholipids, and we observed 
reduction in most of them, especially in the KD genotype. As a further proof of the imbalance 
in lipid metabolism, we quantitated the expression of two genes that have been shown to 
reflect transcriptional control of this process in Drosophila (Fig 5A): transcript levels of 
CG6178, related with lipogenesis [26], were strongly reduced; while transcripts of the 
glucagon analog adipokinetic hormone receptor (AKHR), which participates in lipid 
mobilization [27] where significantly increased in KD. 
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Figure 5. Anaplerotic shift to β-oxidation of lipids in 5-week old flies. A. Schematic 
representation of the regulation of Acetyl-CoA synthesis from mitochondrial pyruvate and β-
oxidation of lipids, with indication of the enzymes and metabolites analysed. B. Estimation of 
the mRNA levels of PDP and PDK, relative ratios of pyruvate/lactate and relative 
mitochondrial ATP abundance as an indication of PDC activation. C. Relative NMR signal of 
pyruvate and key TCA cycle metabolites. D. Relative NMR signals of lipids with significant 
changes. E. Relative mRNA abundance of lipid metabolism enzymes. In bar diagrams data 
are represented as mean ±SEM. *P<0.05, **P<0.01, ***P<0.001. 
 
1.6. A systemic early deficit of insulin signaling precedes the defects in 
carbohydrate and lipid homeostasis 
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Both the KU and the KD models showed a shift in metabolic fuel selection, which is most 
accused in the latter. Similar alterations are usually due to a down-regulation of the insulin 
pathway. When the insulin pathway is activated, Akt is phosphorylated, and it turn it 
phosphorylates FOXO, which is then retained in the cytosol for its degradation. When FOXO 
is not phosphorylated, it translocates to the nucleus to function as a transcriptional regulator. 
One of the FOXO targets is the PDC negative regulator PDK, so one of the main roles of 
FOXO activation is to favor fatty acid oxidation [28], which is consistent with our 
observations. The contact of mitochondria and endoplasmic reticulum (ER) through the 
mitochondria-associated membranes (MAMs) is an important modulator of insulin signaling, 
wherefore an excess or reduction of this contact causes insulin-signaling defects [29, 30]. 
Tethering of mitochondria to the ER is precisely one of the functions of GDAP1, and GDAP1 
over-expression increases the contact of these organelles, while RNAi has the opposite effect 
[10]. Our hypothesis is that up- and down-regulation of Gdap1 alters mitochondria-ER 
contacts and as a consequence there is a deficiency in insulin signaling. To test this 
hypothesis, we investigated whether mitochondria-ER contacts and the insulin pathway were 
altered in our fly models. Most importantly, we performed these experiments in young flies, 
before major metabolic alterations are detectable. 
Our previous work revealed alterations in mitochondrial morphology and localization in 1-
week old models of Gdap1 KU and KD in the fly retina neurons [13]. The retina is a nervous 
tissue where quantitative ultrastructural studies can be performed. We re-analyzed these 
electron micrographs to calculate the number of mitochondria in contact with the ER in 
proportion with the total number of mitochondria (Fig. 6A, B). As it could be expected, this 
analysis revealed that, when compared with control flies, KU retinas had more contacts than 
KD ones. 
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Figure 6. Alterations in mitochondria-ER contacts and insulin signaling in 1-week old 
flies. A. Details of representative micrographs of retinas of the three genotypes with 
mitochondria highlighted in yellow and ER in magenta. B. Quantitation of the percentage of 
mitochondria in contact with the ER. C. Relative mRNA levels of Dilps, 4EBP and InR in 
separated head, thorax and abdomen samples. D. Representative Western blots for 
phosphorylated-Akt (Ser473) and total Akt in the three genotypes, and quantitation of the 
protein abundance and protein ratio in five replicates. In bar diagrams data are represented as 
mean ±SEM. *P<0.05, **P<0.01, ***P<0.001. 
 
In order to have a general view of the activation of the insulin-signaling pathway, we 
measured the expression levels of the Drosophila insulin-like peptides (Dilps, Fig 6C), in 
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head extracts, since these peptides are produced in neuroendocrine cells located in the head 
[31]. On average, expression of Dilp3, Dilp5 and Dilp6 was up-regulated, most dramatically 
for Dilp6. High mRNA levels of these genes could be a response to counterbalance for the 
increase in glycaemia in both genotypes. In addition, we checked the expression of two 
insulin suppression markers, 4ebp and the insulin receptor (InR). These genes are 
transcriptional targets of FOXO, and in conditions of insulin pathway deficiency their 
expression is up-regulated [32]. The expression of 4ebp and InR was strongly elevated  in 
both genotypes in the head, the source of the signal, but also in thorax and abdomen, 
indicating a systemic deficiency in insulin signaling (Fig. 6C).  
The range of immunological tools in Drosophila is narrower than in mammalian models, but 
at least it is possible to test the phosporylation state of Akt as a confirmation of the down-
regulation of the pathway. We estimated the abundance of total Akt and phospho-Akt 
(Ser473) in protein extracts from fly heads. We found a significant reduction in the phospho-
Akt to total Akt ratio in both genotypes, although this could be due to different reasons (Fig 
6D). In the KU flies, phospho-Akt levels are not different from the control, but total Akt is 
more abundant. In contrast, in KD flies total Akt is normal but it is less phosphorylated. These 
features, lower proportion of p-AKT, high Dilp expression, insulin suppression markers (4ebp 
and InR), and high glycaemia in the longer term, are akin to insulin resistance. 
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2. DISCUSSION 
2.1. Metabolic and mitochondrial alterations in flies with altered Gdap1 levels 
In this work we have performed the first NMR metabolomic analysis focused on a Drosophila 
disease model, and our results indicate that this can be a useful tool in pathophysiology 
research and biomarker discovery. In addition to metabolic changes that could be expected, 
such as an amino acid profile consistent with muscular degeneration, our results show that 
Gdap1 expression levels are important in the regulation of mitochondria-ER contacts and the 
insulin pathway. Perturbations of these events are evident early in the life of the Gdap1 KU 
and KD flies, and precede other metabolic changes. In older flies, there are significant 
changes in metabolites related to neuronal and muscular degeneration, and a shift in the 
energy metabolism that favours lipid use as an energy source in detriment of carbohydrates. 
Our results suggest a chain of events linking mitochondrial dynamics to insulin signaling to 
energy metabolism, that can contribute to the disease mechanisms related to mutations in 
GDAP1 and other genes involved in mitochondrial dynamics and neurodegeneration. 
The fact that we observe similar alterations in energy metabolism may seem counter-intuitive, 
but a detailed analysis of our data and the clinical picture in mitochondrial CMT reveals that 
these observations are consistent and can be important to understand some of the underlying 
disease mechanisms. First, the KU and KD models are not identical, although they showed 
similar alterations in insulin signalling and metabolic profile. In fact, we could obtain a model 
to separate them at five weeks of age, which shows that they have distinct metabolic profiles 
in spite of the similarities that we have highlighted. Most important, the fact that tilting the 
balance of mitochondrial fusion and fission in any direction can produce a similar phenotype 
is evident from the genetics of mitochondrial CMT patients. In principle, GDAP1 and MFN2 
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have opposite effect in mitochondrial dynamics, since they promote mitochondrial fission and 
fusion respectively, although this may be an oversimplification.  
Several experiments mainly in cell culture have demonstrated that expression of wild type 
GDAP1 promotes fragmentation but does not prevent fusion, and that dominant and recessive 
mutations have different effects on this function of the protein [7, 10, 33, 34]. Truncating and 
missense recessive mutations produce a loss of function and therefore have reduced 
fragmentation activity, in contrast dominant mutations maintain this activity and instead 
prevent fusion. Therefore, dominant and recessive alleles of GDAP1 can cause a similar 
phenotype by affecting mitochondrial dynamics by opposite mechanisms.  
In summary, an imbalance in mitochondrial fusion/fission dynamics in either direction can 
result in peripheral neuropathy. If the mitochondrial network is too fragmented or too 
aggregated several mitochondrial-related processes are impaired, such as sub-cellular 
localisation, mitochondrial respiration or mitochondria-ER contact-dependent calcium 
homeostasis. Our results show that correct insulin signalling is also dependent on a properly 
balanced mitochondrial dynamics and this could be one of the disease mechanisms 
contributing to mitochondrial CMT neuropathy. 
 
2.2. Emerging links of mitochondrial dynamics, metabolism and 
neurodegeneration 
There is mounting evidence of metabolic alterations in neurodegenerative diseases, especially 
those that involve deregulation of mitochondrial function, structure and localization. A 
metabolic shift similar to our Gdap1 model has been described in a mouse model of ALS, 
another motor neuron disease, involving reduced glycolysis, enhanced lipolysis and up-
regulation of PDK [35]. Diabetes has also been found to be related to neurodegenerative 
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diseases such as Alzheimer’s disease [36] and Friedreich’s ataxia[37]. Insulin signalling and 
PDK activity seem to be central to this link [38].  
This could very well be the case in CMT neuropathy, since several CMT-causing mutations 
and CMT-related genes have a clear metabolic implication. Most strikingly, the other main 
mitochondrial dynamics gene, MFN2, has clear functional links with energy metabolism. 
Studies in mouse Mfn2 have revealed that its effects in mitochondrial dynamics and 
mitochondria-ER contact induce increased gluconeogenesis and impaired insulin signalling in 
the liver and muscle [17]; and neuron-type specific ablation impacts on energy metabolism 
[39, 40]. All this evidence points to Mitofusin 2 as a key regulator of insulin signalling [41] 
Among the CMT causative genes, two of them are clearly involved in energy metabolism, 
hexokinase-1 and PDK3 [42, 43]. Most interestingly, the disease mechanism in PDK3 
mutation has been shown to be a hyperactivation of the PDK3 protein, which results in down-
regulation of PDC [44]. This observation supports our hypothesis that elevated levels of PDK 
are related to the neurodegeneration in KU and KD models. Moreover, a reduction of 
glycolytic enzymes, including PyrK, is also a hallmark of one of the murine models of 
GDAP1 [11]. 
This new evidence indicates that metabolic dysfunction may contribute to the neuronal and 
muscular degeneration either cell-autonomously and/or systemically. In consequence, the 
genes and metabolites involved in energy metabolism are promising candidates for 
biomarkers to evaluate disease progression in these neuropathies. The Drosophila model we 
present here is useful to understand the pathophysiology of clinical GDAP1 mutations, to 
perform further metabolic studies for biomarker discovery and to find new treatments for the 
CMT neuropathy.  
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3. MATERIALS AND METHODS 
 
3.1. Drosophila husbandry and genetics 
OregonR and Act5C-Gal4 stocks were obtained from the Bloomington Drosophila Stock 
Center. UAS-Dcr2, UAS-Gdap1 and UAS-Gdap1RNAi were described previously [13]. Flies 
were maintained on standard cornmeal medium at 25°C. The experimental genotypes were 
obtained by crossing Act5C-Gal4 flies to OregonR (control), UAS-Gdap1 (KU) and UAS-
Gdap1RNAi, UAS-Dcr2 (KD). 
 
3.2. Fitness, geotaxis and weight.  
For the survival test, flies were cultured at 25°C, scored every 2-3 days and transferred to a 
new vial. This assay was done in triplicate for each genotype and at least 120 flies were 
counted per genotype. The negative geotaxis assay was conducted for 10-, 20- and 30-day old 
individuals. Flies were transferred to a tube without food and allowed to settle for 5 min. 
After knocking them down to the bottom of the vial, we scored the percentage of flies that 
reached the top of the vial (9 cm) in 10 seconds (Video S1). This assay was performed in 
quadruplicate for each genotype; at least 120 flies were used per genotype. To calculate 
individual weight, flies were anesthetized in groups of 15 individuals and weighed. This 
experiment was done in quintuplicate for each genotype.  
 
3.3. Metabolite extraction.  
Metabolite extraction was performed with the chloroform-methanol-water extraction 
procedure, widely applied for tissues and cells [45], which has been proven to be fast and 
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convenient and allows to quantify polar and non-polar metabolites. Briefly, flies were 
homogenized in groups of 15 individuals after adding methanol (240 μl), chloroform (120 μl) 
and water (48 μl) into plastic tubes on ice. Samples were vortexed and 120 μl of chloroform 
and 120 μl water were added, then vortexed again. Samples were kept 15 min on ice and then 
centrifuged at 4°C for 15 min, 10.000xg. At this point, two phases were obtained: an aqueous 
phase at the top and a chloroform phase at the bottom. The two phases were separated in 
different tubes, the aqueous phase was lyophilized and the chloroform of the organic phase 
was evaporated under vacuum. Samples were stored at -80°C. 
 
3.4. NMR sample preparation.  
Aqueous extracts were resuspended in 550 μl of NMR buffer (100 mM phosphate, in D2O, pH 
7.4, 0.1 mM 3-(trimethylsilyl)-2,2',3,3'-tetradeuteropropionic acid (TSP)). Samples were 
vortexed, centrifuged at 12.000xg for 5 min and the supernatant transferred to a 5 mm NMR 
tube. The organic extract was resuspended in 600 μl of deuterated chloroform with 0.03% v/v 
Tetramethylsilane (TMS) and centrifuged at 13.000xg for 1 min. 550 μl of the solution were 
transferred to an NMR tube, and the tube was sealed. Samples were stored at 4°C and 
measured the same day.  
For intact fly samples [23, 46], flies were anesthetized and introduced in a 50-µl HRMAS 
rotor. At the top of the rotor, separated by parafilm, 50 µl of D2O was placed. HRMAS 
samples were measured immediately after preparation.  
 
3.5. NMR spectroscopy.  
NMR spectra of the extracts were recorded at 27ºC on a Bruker AVI-600 using a 5-mm TCI 
cryoprobe. The spectra of intact flies were recorded on a Bruker AVII-500 using a 5-mm 
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HRMAS probe with spinning at 2000 Hz. One-dimensional 1H-NMR noesy spectra were 
acquired with 256 free induction decays (FIDs) for the aqueous extracts and 64 FIDs for 
chloroform extracts and intact flies. 64k data points were digitalized over a spectral width of 
30 ppm for extract spectra and 20 ppm for HRMAS spectra. A 3 s relaxation delay was 
included between FIDs and water presaturation was applied for aqueous samples. The FID 
values were multiplied by an exponential function with a 0.5 Hz line broadening factor for 
extracts and 1 Hz for intact cells. Total Correlation Spectroscopy (TOCSY) and multiplicity 
Heteronuclear Single Quantum Correlation (HSQC) were performed for representative 
samples of the aqueous phase and the organic phase of each condition for signal assignment. 
For each of these experiments, 256-512 t1 increments were used and 32-96 transients were 
collected. The relaxation delays were set to 1.5 s and the experiments were acquired in the 
phase-sensitive mode. For extracts, TOCSY spectra were recorded using a standard MLEV-
17 pulse sequence with mixing times (spin-lock) of 65 ms. For the extracts, the TOCSY 
spectra were recorded using a standard MLEV-17 pulse sequence with mixing times (spin-
lock) of 65 µs. For the intact cells, the adiabatic TOCSY experiments [47] were acquired with 
tangential frequency modulation using an adiabatic pulse length of 285 µs and a mixing time 
of 60 ms. 
 
3.6. Metabolite assignment and quantification.  
Metabolite identification and assignment was performed with the help of databases (Amix, 
HMBD [48] and Biological Magnetic Resonance Data Bank), literature values and 
information from 2D NMR experiments. For specific metabolites the assignment was 
confirmed by spiking experiments, consisting in the addition of the compound to a previously 
measured extract sample and the subsequent evaluation of the consistency between the newly 
appearing signals with the proposed assignment. For metabolite quantification, spectra were 
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automatically integrated at selected regions with MestreNova. For a better comparison 
between extract samples, integration values were normalized to total intensity to minimize the 
variability generated by the extraction procedure. In the case of the intact fly samples, the 
Eretic, an artificial signal that was previously calibrated with a reference sample [49], was 
used for metabolite quantification. 
 
3.7. Multivariate analysis.  
Multivariate data analysis was performed with SIMCAP 12.0 (Umetrics, Sweden) with the 
normalized integral values of polar metabolites. Integral tables were pareto scaled (each value 
is divided by the square root of the standard deviation of each variable) for an easier 
interpretation of the data and to take into account small signals. Additionally, mean centering 
was applied to improve the interpretability of the model. To build discriminant models, 
orthogonal projection on latent structure-discriminant analysis (OPLS-DA) [50] analysis was 
performed. OPLS-DA separates predictive variation (between classes) from non-predictive 
(within classes) variation in a single component, thus, clear separations in the score plots are 
obtained. Furthermore, the analysis of S-plots [51] (representation of the magnitude of the 
variables modelled by co-variation versus the reliability of the modelled correlation) allowed 
to define the metabolites that were essential for discrimination. To assess the quality of each 
model, the parameters R2X(cum) (variance of X taken into account by the model), RY(cum) 
(variance of Y that is predicted) and Q2(cum) (goodness of prediction) were evaluated. A 
Q2(cum) value ≥ 0.5 was considered indicative for a good model. Furthermore, the OPLS-DA 
models were validated by performing the permutation test [52] 20 times with equivalent PLS-
models. The coefficients R2 and Q2 generated from the permutation test were compared to 
the R2 and Q2 value of the real model. If intercept R2 and Q2 values from the permutation 
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test were significantly smaller than Q2 of the real model, the model was regarded as 
predictable.  
 
3.8. Mitochondrial ATP levels.  
Mitochondria were isolated from groups of 30 flies for each genotype [13]. Fluorescence was 
normalized to the protein content determined by the Pierce BCA protein assay kit (Thermo 
Fisher Scientific, Inc.). Each sample was analyzed in triplicate. 
 
3.9. Mitochondria-ER contacts.  
We quantified total number of mitochondria in each rhabdomere and then we determined how 
many of them were in contact to the ER. With these figures we calculated the ratio of 
mitochondria in contact with the ER to the total number of mitochondria. 40 ommatidia, each 
one containing 7 neuronal cell bodies, were scored per genotype. 
 
3.10. Quantitative RT-PCR.  
RNA extraction was performed with Trizol Reagent in groups of 20 flies for each genotype. 
Reverse-transcription was made with qScript cDNA supermix (Quanta Biosciences, 
Gaithersburg, MD, USA). Quantitative real-time PCR was performed with 5’ FAM-labeled 
probes of the Roche Universal Probe Library (Roche, Basel, Switzerland) in an Applied 
Biosystems 7900HT Fast Real-Time PCR system (Thermo Fisher Scientific, Inc.). PCR 
primer pairs and probes were determined using the Roche Universal Probe Library Assay 
Design Tool. Primer sequences and probes are indicated in the table below. Each sample was 
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analyzed in triplicate, and the expression was calculated according to the 22DDCt method. 
Expression levels were normalized relative to the expression of Gapdh1 and Rp49. 
 
3.11. Western blotting.  
For Western blot analysis, 5 replicas were made for each genotype. For each individual 
sample, 25 fly heads were pooled. Extraction was carried out in RIPA buffer with protease 
and phosphatase inhibitors, samples were heated to 95°C for 5 min before loading. The 
samples were electrophoresed in 12% SDS – PAGE, and the separated proteins were 
transferred onto Nitrocellulose membrane (Whatman GmbH, Dassel, Germany). After 
transfer, membranes were blocked with BSA 5% in TBS-T. Primary antibodies were AKT 
(1:1000, Cell Signaling. #9272) and phosphor-AKT (Ser 473) (1:1000, Cell Signaling. 
#9271). The blots were washed three times with TBS-Tween and further incubated for 1 h 
with a secondary anti-rabbit antibody conjugated with horseradish peroxidase. The membrane 
was washed three times 5 min with TBS–Tween, Luminol ECL Western Blotting Detection 
Reagent (GE Healthcare, Little Chalfont, UK) was added onto the membrane, 1 
ml/membrane, and chemiluminescence was detected in an ImageQuant LAS-4000 image 
reader (GE Healthcare). Results were then analyzed with the Image Gauge 4.0 software. 
Quantitation of the Akt proteins was carried out by comparing band intensity with an actin 
standard. 
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